RCIM
TEVA icon

Russell Clark Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Russell Clark Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,000
Closed -$452K – 34
2016
Q2 		$452K Hold
9,000
– – 0.1% 28
2016
Q1 		$482K Buy
9,000
+5,000
+125% +$293K 0.14% 18
2015
Q4 		$263K Hold
4,000
– – 0.07% 21
2015
Q3 		$226K Hold
4,000
– – 0.06% 25
2015
Q2 		$236K Buy
+4,000
New +$247K 0.06% 26

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Russell Clark Investment Management's TEVA Position: Q3 2016 in Review

Russell Clark Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 9,000 shares — an estimated $452K sold.

Russell Clark Investment Management first reported a position in TEVA in Q2 2015 and held it in 5 quarters. The position peaked at $482K in Q1 2016. 796 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Russell Clark Investment Management reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Russell Clark Investment Management sold 9,000 Teva Pharmaceuticals shares in Q3 2016, an estimated $452K.
  • Russell Clark Investment Management first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 5 quarters.
  • Russell Clark Investment Management's Teva Pharmaceuticals position peaked at $482K in Q1 2016.
  • 796 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Russell Clark Investment Management's 13F filing for Q3 2016, filed 9 Nov 2016.